Long-term peritoneal membrane changes

被引:37
作者
Coles, GA [1 ]
Topley, N [1 ]
机构
[1] Univ Wales Coll Cardiff, Coll Med, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales
来源
ADVANCES IN RENAL REPLACEMENT THERAPY | 2000年 / 7卷 / 04期
关键词
peritoneal dialysis; functional change; structural change; peritoneal transport; ultrafiltration failure; biocompatibility; peritoneal sclerosis;
D O I
10.1053/jarr.2000.16268
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
There is increasing evidence that long-term peritoneal dialysis (PD) is associated with structural changes in the peritoneal membrane. These consist of thickening of the sub-mesothelial space owing to collagen deposition and alterations in small blood vessel morphology. These alterations become more pronounced with duration of PD therapy. These changes are associated with a tendency to increasing small solute transport rate with reduced ultrafiltration. The relationship between these structural and functional changes remains unknown, but the evidence suggests that both peritonitis and exposure to dialysate contribute. The most likely components of the fluid responsible for this effect are glucose and/or its degradation products generated during heat sterilisation. Serial monitoring of peritoneal function is well established, but repeat biopsies are not practical. Effluent markers are not yet of proven value but do alter in response to a change in dialysate composition. Hopefully, a combination of reduced inflammation and more biocompatible fluids will reduce long-term changes in peritoneal membrane structure and function with a consequent improvement in patient and technique survival. (C) 2000 by the National Kidney Foundation, Inc.
引用
收藏
页码:289 / 301
页数:13
相关论文
共 110 条
[1]  
ALOBAIDI H, 1986, THESIS U WALES
[2]   MECHANISMS OF POLYMORPHONUCLEAR LEUKOCYTE-MEDIATED PERITONEAL MESOTHELIAL CELL INJURY [J].
ANDREOLI, SP ;
MALLETT, C ;
WILLIAMS, K ;
MCATEER, JA ;
ROTHLEIN, R ;
DOERSCHUK, CM .
KIDNEY INTERNATIONAL, 1994, 46 (04) :1100-1109
[3]  
[Anonymous], 1997, Am J Kidney Dis, V30, pS67
[4]  
Bellingan GJ, 1996, J IMMUNOL, V157, P2577
[5]  
BOS WJW, 1998, PERITON DIALYSIS INT, V18, pS12
[6]   INTERLEUKIN-6 AND INTERLEUKIN-8 IN DIALYSATE AND SERUM FROM PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
BRAUNER, A ;
HYLANDER, B ;
WRETLIND, B .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (03) :430-435
[7]   TOXICITY OF OSMOTIC SOLUTES ON HUMAN MESOTHELIAL CELLS-INVITRO [J].
BREBOROWICZ, A ;
RODELA, H ;
OREOPOULOS, DG .
KIDNEY INTERNATIONAL, 1992, 41 (05) :1280-1285
[8]   SCLEROSING PERITONITIS - IDENTIFICATION OF DIAGNOSTIC, CLINICAL, AND RADIOLOGICAL FEATURES [J].
CAMPBELL, S ;
CLARKE, P ;
HAWLEY, C ;
WIGAN, M ;
KERLIN, P ;
BUTLER, J ;
WALL, D .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (05) :819-825
[9]  
CANNISTRA SA, 1994, EXP HEMATOL, V22, P996
[10]  
Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285